PG Medical Admissions 2024 in Karnataka: KEA to close application window tomorrow, register now

Karnataka- Karnataka Examinations Authority (KEA) is going to close the application window for PG medical degree, DNB, and diploma courses. Candidates who have qualified the National Eligibility and Entrance Test-Postgraduate (NEET PG) 2024 and meet the eligibility criteria for PG medical courses can apply for the programme. The last date to apply for admission is tomorrow i.e. October 5, at 5:30 pm.

Candidates will be allotted seats in government medical colleges, government quota seats in private and minority medical colleges, and private seats in private and minority medical colleges such as KPCF, KRLMPCA, AMPCK, and private universities of Karnataka.

Candidates who have secured a minimum percentile or above in NEET PG 2024 are eligible to register for admission to postgraduate medical courses. However, candidates from outside Karnataka will have no seat reservation quota applicable to their applications.

The general category candidates who have obtained the minimum percentile in NEET-PG 2024 i.e. 50th percentile are eligible to apply and register for KEA admissions. Moreover, the SC, ST, and OBC eligibility criteria will be only applicable to SC, ST, and OBC candidates of Karnataka.

Meanwhile, the details regarding the registration fee, document verification schedule, and original documents to be submitted for document verification will soon be published on the KEA official website.

However, KEA does not entitle candidates to admission if they are unable to fulfil the eligibility criteria or fail to produce the prescribed certificates for document verification. Candidates who register and complete the document verification process will be eligible for admission to PG medical and dental courses in government and private colleges in Karnataka.

Karnataka Examinations Authority is governed by the Governing Council headed by the Honourable Minister of Higher Education. The Government of Karnataka established Common Entrance Test Cell in the year 1994 for conducting of entrance test and determining the eligibility/merit, for admission to the first year or first semester of full-time professional courses for Government share of seats in Medical, Dental, Indian systems of medicine and Homeopathy, B-Pharma, Pharma-D Courses, etc.

Powered by WPeMatico

Liver X receptor beta: A new frontier in treating depression and anxiety

In a Bench to Bedside review published in the journal Brain Medicine, researchers Dr. Xiaoyu Song and Professor Jan-Åke Gustafsson from the University of Houston and Karolinska Institutet (Sweden) shed light on the therapeutic potential of liver X receptor beta (LXRβ) in treating depression and anxiety. This comprehensive analysis marks a significant step forward in understanding the molecular underpinnings of mental health disorders and potentially revolutionizing their treatment.

Powered by WPeMatico

Kids missed out on learning to swim during pandemic, widening racial and ethnic disparities

Nearly three out of four kids in Chicago had no swimming lessons in the summer of 2022, with significant racial and ethnic differences, according to a parent survey from Ann & Robert H. Lurie Children’s Hospital of Chicago published in Pediatrics. Black and Hispanic/Latine kids were disproportionately affected (85% and 82%, respectively), compared to white kids (64%).

Powered by WPeMatico

Study finds toddlers get nearly half their calories from ultra-processed foods

Toddlers in the UK obtain nearly half (47%) of their calories from ultra-processed foods (UPFs), and this rises to 59% by the age of seven, according to a new study led by UCL researchers.

Powered by WPeMatico

Water fluoridation found to be less effective now than in past

The dental health benefits of adding fluoride to drinking water may be smaller now than before fluoride toothpaste was widely available, an updated Cochrane review has found.

Powered by WPeMatico

Study demonstrates that mpox vaccine antibody responses wane within a year

A study led by researchers at Beth Israel Deaconess Medical Center (BIDMC) has demonstrated that mpox antibody levels declined rapidly and nearly returned to baseline six to 12 months after patients received the mpox vaccination. The findings, published in JAMA, suggest that protective immunity may have waned in previously vaccinated individuals and that boosting may be required to maintain robust protection.

Powered by WPeMatico

RG Kar PG Medico Rape-Murder Case: Junior doctors hold mega protest march, unveil victim’s statue

Kolkata: Thousands of junior doctors, joined by supporters from various walks of life, marched in protest on Wednesday, demanding justice for a postgraduate medico who was raped and murdered at R G Kar Medical College and Hospital in August.

The demonstration, organized by the Bengal Junior Doctors’ Front, commenced at College Street and concluded at Esplanade, escalating the ongoing agitation for improved safety measures for healthcare workers.

According to the PTI report, “We are not in a ‘Puja’ or ‘Utsav’ mood, and we will continue protesting on the streets till our sister gets justice. We have chosen this day of Mahalaya to send out this message,” said one of the protesters, identifying herself as a colleague of the deceased. 

Also Read:RG Kar Case: ‘Why Progress on safety measures so tardy?’ SC pulls up WB Govt, seeks National Task Force’s Report

Mahalaya marks the beginning of Devi Paksha in the Hindu calendar, heralding the start of Durga Puja celebrations, when devotees invoke Goddess Durga to descend to Earth.

Carrying placards, and national flags, the protesters raised slogans, asserting they would not rest until justice was served. 

The march comes amid doctors’ ‘cease-work’ stir in hospitals in protest against the rape and murder of their colleague.

As the rally concluded at Esplanade, leaders of the Bengal Junior Doctors’ Front vowed to continue their agitation until the government took definitive action.

“We will not give up. This is about our safety, our dignity, and justice for Abhaya. The government cannot expect us to remain silent while they do nothing,” said an agitating junior doctor, while addressing the crowd, news agency PTI reported.

The rally, one of the largest demonstrations in recent weeks, attracted a diverse mix of participants, including doctors, nurses, medical students, and concerned citizens.

The protesters later gathered on the banks of Ganga, lighting 1,000 diyas as a symbolic act in their fight for justice.

Despite the festive air in the city as people prepared for the upcoming Durga Puja, protesters maintained that the movement for justice overshadowed celebrations.

“Today is the 52nd day of our protest, and we are still facing attacks. There is no positive response from the state government toward meeting our safety and security demands,” said Aniket Mahato, one of the agitating junior doctors, addressing the crowd at Esplanade.

The protesters, mostly junior doctors, have been on a ‘cease work’ since Tuesday, accusing the West Bengal government of failing to fulfil promises made in mid-September.

Although the doctors had partially resumed services after 42 days of the strike, they went back to ‘cease-work’ on Tuesday, alleging that key demands such as enhanced safety measures for medical staff were not implemented.

Among the key demands raised by the Bengal Junior Doctors’ Front are the installation of CCTV cameras on hospital premises, round-the-clock security for healthcare workers, and stricter protocols to prevent similar incidents of violence against medical professionals.

The culture of fear and intimidation within state-run hospitals has also been a focal point of the protests, with the doctors alleging that the administration has failed to provide a safe working environment.

“We joined our profession to serve the people, but how can we do so when we constantly live in fear? We don’t feel safe in the very places where we are supposed to save lives,” said another junior doctor.

While the West Bengal government had initially promised to address many of the doctors’ concerns following the first phase of protests, the agitating doctors claimed there has been little follow-up action.

“The promises made were hollow. We are being asked to return to work without any concrete measures being put in place to ensure our safety,” Mahato said.

Attempts by the government to broker peace with the doctors have so far failed, with state officials urging the medics to return to work and suggesting that police investigations into the alleged murder of the junior doctor are ongoing.

The junior doctors’ protest has garnered widespread support from Kolkata’s general public, with many residents expressing solidarity with the movement.

“This is not just about doctors. This is about justice, about safety in our institutions, and about holding those in power accountable,” said Swati Mukherjee, a homemaker who joined the rally along with her family.

With no clear resolution in sight, and tensions between the junior doctors and the state government intensifying, the protest movement looks set to continue in the coming weeks, even as Kolkata prepares for its biggest festival of the year.

Meanwhile, a statue christened ‘Abhaya’ was unveiled on RG Kar Hospital premises, which the agitating doctors claimed is a symbol of the ghastly act that occurred on August 9 and also of the ongoing protests demanding justice, adds PTI.

“This statue is not of the victim, but a symbol of pain, torture she went through and the ongoing protests,” a junior doctor of the hospital told reporters.

Also Read:Kolkata Doctor Death Case: Bengal Doctors hold torch rally ahead of SC hearing

Powered by WPeMatico

12 Indian Cardiologists, Scientists Get Recognised in Standford University 2024 list of World’s Top 2 percent Scientists

New Delhi: Altogether 12 renowned cardiologists, haematologists and scientists from various prestigious health and medical institutes across India have received recognition among the world’s top 2% of scientists in the prestigious database curated by Professor John P.A. Ioannidis of Stanford University, in collaboration with the Elsevier Data Repository. This honour acknowledges their pioneering research, clinical achievements, and consistent impact on the field.

The database of Stanford University for the year 2024 of top-cited scientists provides standardized information on citations, h-index, co-authorship adjusted hm-index, citations to papers in different authorship positions and a composite indicator (c-score). The selection is based on the top 100,000 scientists by c-score (with and without self-citations) or a 2% or above percentile rank in the sub-field.

Here are the details of the Indian Cardiologists and Scientists featured in Stanford University’s list for 2024:

Dr Ambuj Roy: 

A renowned Professor of Cardiology and Head, Skill, E-Learning and Telemedicine Facility at the All India Institute of Medical Sciences (AIIMS), New Delhi, Dr. Ambuj Roy is a fellow of the American College of Cardiology, National Academy of Medical Sciences and Royal College of Physicians (Edinburgh). He is the past Convenor of the Heart Failure Council of the Cardiological Society of India.

Dr. Roy, a clinician-researcher with vast experience in managing cardiovascular disease patients in low-resource settings in the premiere medical institute of India, has been recognised as one of the top 2% scientists across the world, as per Stanford University’s list of 2024.

As per the list, Dr. Roy holds a rank of 1,25,187 in the list based on the composite score excluding self-citations, and 128,717 when all citations are included. By the end of 2023, Dr. Roy’s h-index, excluding self-citations, stands at 25, with altogether 7,925 citations for 2023 (excluding self-citations). 

He is a member of the Institute Body of Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry. He also serves on several advisory committees in the Ministry of Health and Family Welfare, Govt. of India and Task Force Committee of ICMR for Cardiovascular Research in India.

His research focuses on cardiovascular epidemiology, heart failure and translational research to improve CV risk factor management using technology including MHealth. He has many seminal research papers including the role of alcohol and influenza vaccine in cardiovascular disease prevention.

Dr. Dorairaj Prabhakaran: 

Professor D. Prabhakaran, who is a cardiologist and epidemiologist by training, is also an internationally renowned researcher and is the Executive Director of the Centre for Chronic Disease Control, New Delhi, a Distinguished Professor of the Public Health Foundation of India, and a Professor (Epidemiology) at the London School of Hygiene and Tropical Medicine, UK.

He heads the NIHR Centre for Global Health at Public Health Foundation of India. These centres conduct cutting-edge research to prevent chronic diseases in India and the developing world. Dr. Prabhakaran has now received recognition as one of the top 2% scientists across the world, as per the Stanford University’s list of 2024.

As per the list, Dr. Prabhakaran holds a rank of 16,180 in the list based on the composite score excluding self-citations, and 16,517 when all citations are included. By the end of 2023, his h-index, excluding self-citations, stands at 37, with altogether 10,955 citations for 2023 (excluding self-citations).

His work spans from mechanistic research to understanding the causes of increased propensity of cardiovascular diseases (CVD) among Indians to developing solutions for CVD through translational research and human resource development.

Prof. Prabhakaran is a Fellow of the Royal College of Physicians, UK, a Fellow of the National Academy of Sciences, India, a Fellow of the Indian National Science Academy and an Adjunct Professor at the Emory University. He is a member of the Executive Council of the International Society of Hypertension (ISH) and the International Society of CVD Epidemiology and Prevention (ISCEP). He has received funding from NHLBI, Wellcome Trust, the European Commission and several other international and national funding bodies.

He has mentored over 50 post-doctoral and doctoral students so far. He has authored several chapters and over 700 scholarly papers with an H index of 115. He was listed as the topmost researcher in Medicine in India in terms of publications for 2009-2014 by Scopus and Department of Science & Technology, Government of India.

He is the lead editor of the Cardiovascular Disease Volume of the latest Disease Control Priorities Project. He is the lead editor of Tandon’s textbook of Cardiology, a comprehensive book on Cardiology for Indian Cardiologists and Fellows. Recognizing his work in Chronic Diseases and Global Health, he was conferred an Honorary Doctor Of Science degree from Glasgow University.

Dr. Manish Bansal: 

Dr Manish Bansal is currently Senior Director in Cardiology at Medanta- The Medicity, Gurgaon, India. He pursued his MBBS from Maulana Azad Medical College, MD in Medicine from AIIMS Delhi, DNB Cardiology from Escort Heart Institute & Research Centre, and thereafter Fellowship in Cardiac Imaging from the Department of Cardiology, University of Queensland, Brisbane, Australia.

Trained at the premier medical institutes in India and abroad, including the All India Institute of Medical Sciences and the Princess Alexandra Hospital, Brisbane, Australia, Dr Manish Bansal has had an illustrious academic career with several Gold-medals (Pathology, Pediatrics, Cardiology) and recognitions (FACC, FASE, FISCU, Excellence in Cardiology awards, etc) to his credit. He has more than twenty years of experience in treating all forms of cardiac illnesses, including coronary artery disease, valve diseases, cardiomyopathies, etc.

Dr. Bansal has special expertise in the field of early detection, prevention and management of coronary artery disease, the leading cause of death in our country. He has extensively researched in this area and has contributed significantly to the knowledge-base on this subject. He is also a leading specialist in echocardiography, with particular interest in advanced echocardiographic techniques such as stress echocardiography, strain imaging, 3D echocardiography etc.

Apart from his clinical experience, Dr Bansal is an avid researcher with more than 250 publications in leading indexed national and international journals and books. He has previously been the Editor-in-chief of Indian Heart Journal and the Journal of Indian Academy of Echocardiography & Cardiovascular Imaging and has also been on the editorial board of several leading national and international journals such as JACC Imaging and Cardiovascular Ultrasound. He has also been a mentor to students undergoing training in Cardiology and Echocardiography at Medanta- The Medicity and is regularly invited as faculty in various national and international meetings.

Now, Dr. Bansal has been recognised as one of the top 2% scientists across the world, as per the Stanford University’s list of 2024. According to the list, Dr. Bansal holds a rank of 73,458 in the list based on the composite score excluding self-citations, and 64,343 when all citations are included. By the end of 2023, his h-index, excluding self-citations, stands at 8, with altogether 585 citations for the year 2023 (excluding self-citations).

Dr. Ponnysamy Shunmuga Sundaram: 

Dr. P Shunmuga Sundaram pursued his MBBS in 2005, followed by an MD degree in General Medicine (2006-2009). He also pursued DM Cardiology during 2010-2012 from Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Thiruvananthapuram and later held the post of a Post-Doctoral Fellow in Cardiac Electrophysiology. Thereafter, he received Advanced Cardiac Electrophysiology Training from St. Luke’s Medical Centre, USA in 2014.

As per Standard University’s list of 2024, Dr. Sundaram has been recognised as one of the top 2% scientists across the world. He holds a rank of 319,279 in the list based on the composite score excluding self-citations, and 194,828 when all citations are included. By the end of 2023, his h-index, excluding self-citations, stands at 8 with altogether 283 citations for the year 2023 (excluding self-citations).

He received the Young Researcher Award from the Global Indian Electrophysiology Forum, Boston in 2024 and the Best Researcher Award- 2024 by Dr. MGR Medical University, Tamil Nadu.

Dr. Raman Krishna Kumar: 

Dr. Raman Krishna Kumar is a distinguished pediatric cardiologist and he serves as the Clinical Professor and Head of the Department of Pediatric Cardiology at Amrita Hospital in Kochi. He pursued his MBBS from Maulana Azad Medical College and MD from Primary Specialty Board in Internal Medicine, All India Institute of Medical Sciences, New Delhi.

Thereafter, he pursued DM Cardiology from AIIMS, New Delhi. He also was an International Fellow of the American Heart Association (FAHA) conferred by the Council on Lifelong Congenital Heart Disease and Heart Health in the Young. Dr. Kumar was also an Honorary Fellow of Sri Lankan College of Cardiology.

Since 1998, he has played a pivotal role in establishing and leading the pediatric heart program at Amrita Hospital, Kochi elevating its status through exceptional clinical services, research endeavors, and training programs. 

Dr. Raman Krishna Kumar has been recognised as one of the top 2% scientists across the world, as per the the Stanford University’s list of 2024. According to the list, Dr. Kumar holds a rank of 78,155 in the list based on the composite score excluding self-citations, and 69,519 when all citations are included. By the end of 2023, his h-index, excluding self-citations, stands at 12, with altogether 2,091 citations for the year 2023 (excluding self-citations).

Dr. Kumar’s clinical focus spans echocardiography, catheter interventions, and intensive care, catering to the diverse needs of his patients. With over 250 publications and a commitment to advancing pediatric cardiac care, Dr. Krishna Kumar’s legacy continues to impact the lives of young patients globally, shaping the future of pediatric cardiology.

 Dr. Ganesan Karthikeyan: 

Dr. Ganesan Karthikeyan pursued his MBBS from the Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) in 1993. Thereafter, he pursued MD in General Internal Medicine in 1997 from JIPMER. He also pursued DM Cardiology from All India Institute of Medical Sciences (AIIMS). He worked at the Department of Cardiology of AIIMS for more than 22 years. As per the institute’s website, Prof Karthikeyan is currently on deputation to Translational Health Science and Technology Institute, Faridabad.

Stanford University’s list of 2024 also recognised Dr. Ganesan Karthikeyan as one of the top 2% of scientists across the world. According to the list, Dr. Karthikeyan holds a rank of 90,367 in the list based on the composite score excluding self-citations, and 72,437 when all citations are included. By the end of 2023, his h-index, excluding self-citations, stands at 19, with altogether 5,244 citations for the year 2023 (excluding self-citations).

 Dr. Denis Xavier: 

Dr. Denis Xavier pursued his MBBS from St. John’s Medical College, Bangalore in 1992. Thereafter, he pursued MD Pharmacology from Bangalore University and MSc in Clinical Epidemiology and Biostatistics from McMaster University, Hamilton, Ontario, Canada. 

He is the Head of the Clinical Research and Training Division at St. John’s Research Institute and he also Heads the Pharmacology Department of St John’s Medical College.

Dr. Xavier has now been recognised as one of the top 2% scientists across the world, as per the Stanford List for 2024, for his research on Cardiovascular Systems and Hematology. 

According to the list, he holds a rank of 92,825 in the list based on the composite score excluding self-citations, and 99,958 when all citations are included. By the end of 2023, his h-index, excluding self-citations, stands at 36, with altogether 10,061 citations for the year 2023 (excluding self-citations).

 Dr. Sivadasanpillai Harikrishnan: 

Dr. Sivadasanpillai Harikrishnan pursued his MBBS from the Medical College in Trivandrum in 1991. Thereafter he pursued MD in General Medicine from the University of Calicut and DM Cardiology from Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Trivandrum.

He also holds a DNB Cardiology Degree from the National Board and Commonwealth Fellowship in Coronary Interventions from Leeds University, U.K. He also attended the Public Health Leadership and Implementation Academy Programme from Emory University, Atlanta, USA in 2014-2015. He has been the Head of the Cardiology Department at SCTIMST since 2023.

According to Stanford University’s list for 2024, Dr. Harikrishnan has been recognised as one of the top 2% of scientists across the world. As per the list, Dr. Harikrishnan holds a rank of 99,243 in the list based on the composite score excluding self-citations, and 94,564 when all citations are included. By the end of 2023, his h-index, excluding self-citations, stands at 20, with altogether 7,173 citations for the year 2023 (excluding self-citations).

Dr. Harikrishnan received the MS Valiathan award for the “Outstanding Research Investigator Award” by SCTIMST in 2022 and Amrut Mody Unichem Prize in 2018 from the Indian Council of Medical Research (ICMR) for excellence in research in the field of cardiology, Heart Failure. Further, he received Society for Heart Failure and Transplantation (SHFT) Excellence in Publication Award in 2018 and “Challenging Case – OCT” award in the Advanced Cardiovascular Therapeutics, Chennai, 2015. Dr. Harikrishnan also won the best case award in the National Interventional Council meet of Cardiological Society of India, Hyderabad, April 26, 2009.

 Dr. Asru K. Sinha: 

Dr. Asru K. Sinha, from Sinha Institute of Medical Science and Technology, Kolkata, has also been recognised as one of the top 2% of scientists across the world, as per the Stanford University’s list of 2024. According to the list, Dr. Sinha holds a rank of 101,194 in the list based on the composite score excluding self-citations, and 116,729 when all citations are included. By the end of 2023, his h-index, excluding self-citations, stands at 3, with altogether 284 citations for the year 2023 (excluding self-citations).

 Dr. Alok Srivastava: 

Dr. Alok Srivastava works as a Professor and Head of the Department of Haematology at the Christian Medical College, Vellore. He pursued his MBBS and MD in General Medicine from the University of Madras and thereafter was a Fellow of the Royal Australasian College of Physicians in 1993. He also was a Fellow of the Royal College of Physicians, UK in Haematology in 2004.

He also Heads the Centre for Stem Cell Research at CMC Vellore. Dr. Srivastava is also Chair of the National Apex Committee of the Stem Cell Research and Therapy, DHR, Union Government, and Vice-Chair of the Centre for International Blood and Marrow Transplantation Research, USA. Further, he also is the Vice-President of World Federation of Hemophilia, Canada.

As per Stanford University’s list of 2024, Dr. Alok Srivastava has also been recognised as one of the top 2% of the scientists across the world. According to the list, Dr. Srivastava holds a rank of 123,118 in the list based on the composite score excluding self-citations, and 119,421 when all citations are included. By the end of 2023, his h-index, excluding self-citations, stands at 10, with altogether 678 citations for the year 2023 (excluding self-citations).

 Dr. Anita Saxena: 

Dr. Anita Saxena, MD, DM (Cardiology), FACC is a Cardiologist of International repute. Before joining Pt. B D Sharma University of Health Sciences and Research at Rohtak, she has held the positions of Dean of Academics, Chief Cardiothoracic Centre and Head of the Cardiology department at the prestigious All India Institute of Medical Sciences, New Delhi. She has over 36 years of professional experience in clinical work, research, and teaching.

Dr Saxena has worked extensively in the subspecialty of Pediatric Cardiology and is an authority on congenital and rheumatic heart diseases. She has led a number of projects for advancing the care of children with heart diseases and has been instrumental in starting dedicated structured training program, DM in Pediatric Cardiology, at the All India Institute of Medical Sciences, New Delhi.

She has over 330 papers published in reputed national and international journals, with a total citation index of over 6700. In addition, she has completed a number of large community-based projects related to public health. She has been teaching DM Cardiology students for more than 36 years and more than 40 doctoral students have completed research projects under her guidance. She has formulated and published national guidelines for the management of congenital heart disease in India.

Dr. Anita Saxena has also received recognition as one of the top 2% scientists across the world under the Stanford University’s list of 2024. As per the list, Dr. Saxena holds a rank of 146,683 in the list based on the composite score excluding self-citations, and 150,221 when all citations are included. By the end of 2023, her h-index, excluding self-citations, stands at 8, with altogether 439 citations for the year 2023 (excluding self-citations).

Dr. Saxena has been frequently invited as an expert group member by the Ministry of Health and Family Welfare, Government of India, Indian Council of Medical Research and other national bodies for formulation of policies and guidelines related to the specialty of cardiology. She is a member of several International Advisory Boards related to Rheumatic heart disease and community health, including Task Force on “Rheumatic Heart Disease” by World Heart Federation. Dr Saxena has also served at Wessex Health Sciences Centre in United Kingdom and has been a Visiting Professor of Pediatric Cardiology, Children’s Hospital, University of Manitoba, Canada from 2001-2010. Dr Saxena has served as President of Asia Pacific Pediatric Cardiac Society, Pediatric Cardiac Society of India, and is a member of several other national and international societies, including National Academy of Medical Sciences and a fellow of American College of Cardiology.

 Dr. Sivasubramanian Ramakrishnan: 

Dr. Sivasubramanian Ramakrishnan is a Professor at the Cardiology Department of the All India Institute of Medical Sciences (AIIMS), New Delhi. He pursued his MBBS from Madurai Medical College and MD (Medicine) from King George Medical College, Lucknow. He joined the Cardiology Department of AIIMS as a Senior Resident in 2001. After completing his DM in 2004, he worked as a faculty member at the GB Pant hospital, New Delhi before rejoining AIIMS as Assistant Professor in October 2005. 

He is actively involved in clinical research, patient care, and educational activities. Dr. Ramakrishnan has authored around 170 publications in indexed journals and his papers have been cited more than 3500 times. He has won numerous awards including D P Basu award, Nanda award, Sujoy B Roy award, Best poster awards in ACC, AEPC and APPCS, Young investigator award in PCSI, APPCS and Col Chopra award. He is involved in providing tertiary patient care services to a vast majority of population, with the quality of care comparable to any cardiac center in the world.

As per Stanford University’s list of 2024, Dr. Sivasubramanian Ramakrishnan has received recognition as one of the top 2% scientists across the world. According to the list, Dr. Ramakrrishnan holds a rank of 272,197 in the list based on the composite score excluding self-citations, and 165,267 when all citations are included. By the end of 2023, his h-index, excluding self-citations, stands at 8, with altogether 375 citations for the year 2023 (excluding self-citations).

He has also organized several updates, national and international conferences and cardiology workshops. As a faculty member at AIIMS, he has been predominantly involved in Clinical Cardiology & interventional cardiology. Apart from his academic, clinical and research work he has attained a high degree of proficiency in interventions. He has performed a few innovative interventions and he is among the first to use alcohol ablation for RVOT obstruction. Dr Ramakrishnan is also awarded a Fellowship of the ACC (American college of Cardiology) and FSCAI.

Also Read: 13 Gynaecologists, Scientists earn global recognition in Standford University 2024 list of World’s Top 2% Scientists

Powered by WPeMatico

Mumbai: Fake Ayurvedic tretament racket busted, 4 held

Mumbai: In a shocking incident that highlights vulnerabilities within healthcare systems, four people have been arrested in Mumbai for allegedly duping patients with bogus ayurvedic medicines claiming to cure serious diseases, including cancer.  

The Bhoiwada police apprehended the suspects for defrauding patients in various Mumbai hospitals by selling fake Ayurvedic remedies. The fraudsters allegedly exploited patients’ desperation and financial vulnerability, charging them exorbitant fees. This has raised serious concerns about patient safety and the potential exploitation of individuals seeking medical treatment.

Also Read: Fake antibiotic medicines worth Rs 17.5 lakh seized in raids across Gujarat

Police reports indicate that the fraudsters specifically targeted patients and their families outside well-known healthcare facilities, such as KEM Hospital, Bai Jerbai Wadia Hospital for Children, and Tata Memorial Hospital. Approaching families in distress, the scammers presented what they claimed were miracle cures in return for significant sums of money.

The so-called “medicines” sold by the fraudsters were nothing more than powdered substances or juices made from common ingredients like bitter gourd, bottle gourd, gooseberry, tulsi, and coconut oil. While these items are often praised for their health benefits, they lack any proven efficacy in treating serious conditions such as cancer. By misleading desperate patients, the fraudsters not only exploited their emotional vulnerabilities but also posed significant health risks. 

Sachin Kadam, the senior police inspector at the Bhoiwada police station, confirmed that an offense had been registered against the four individuals. The accused include a 29-year-old resident of Andheri, a 27-year-old from the same area, a 36-year-old from Mankurd, and a 24-year-old also from Mankurd.

Several patients informed the police about a gang that had cheated them by promising a 100% cure for various diseases via Ayurveda.

According to the Hindustan Times, a police officer said, “They used to charge between ₹5,000 and ₹2.5 lakh for the fake medicines, depending on the patient’s financial status and urgency. We had registered a case in 2022, in which they had taken ₹2.5 lakh from a patient promising him a complete cure.”

The police officer added that juices or powders were given to patients. Tulsi juice, bottle gourd, and bitter gourd were mixed with coconut oil and presented to patients or their relatives, who were told it was a medicine that would cure them within a month. If anyone approached them after a month of treatment, they were referred to a Thane Ayurvedic center.

The police highlighted that the accused had no formal qualifications or licenses to practice Ayurveda or sell medicines. Samples of the concoctions they sold have been collected for forensic testing to support the investigation further.

The suspects were apprehended following police surveillance outside KEM Hospital, where they were actively trying to sell their fraudulent products. They have been charged under sections 125B (acts endangering life or personal safety of others) and 318 (cheating) of the Bhartiya Nyaya Sanhita, 2023. 

Also Read: Hyderabad: Spurious drugs racket busted, Rs 26 lakh stocks seized

Powered by WPeMatico

Pay Rs 3 lakh as penalty for discontinuation of PG medical courses in Andhra this year

All the PG medical candidates getting admitted to Dr NTR University of Health Sciences will have to pay Rs 3 lakh as a discontinuation penalty if they do not complete their courses.

In this regard, the selected candidates will have to execute a bond at the time of admission. This rule applies to all the candidates getting admitted to either the competent authority quota or management quota seat for the academic year 2024-2025.
For more details, click the link below

Powered by WPeMatico